Loading
Latest filing published 14 Jul 2022 for Marrone BIO Innovations INC.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Matti Tiainen, listed as senior executive, appears in our data through filings on Marrone Bio Innovations Inc shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 8 June 2021 and the latest from 12 July 2022.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 14 July 2022: a transaction, in Marrone Bio Innovations Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations